General Practice · Los Angeles, CA
NPI
1679509871
Since 2006
Specialty
General Practice
Code 174400000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
12340 Santa Monica Blvd Ste 302
Los Angeles, CA, 90025
Phone (310) 268-7707
Groups this clinician bills Medicare through
Medicare paid, 2024
$331K
5,662 services
Medicare patients, 2024
808
Average age 77
Drug cost, 2024
$6.7M
29,925 prescriptions
Company payments, 2025
$3,529
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Manouchehr Rashti was code 99213 (office e&m - established), 4,515 times for 771 patients. In total Manouchehr Rashti billed 5,662 services in 11 codes, and Medicare paid $331K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 4,515 | 771 | $66.01 | $298K |
| 36415 Venipuncture Blood Collection | Office | 786 | 463 | $8.65 | $6,799 |
| 99214 Office E&M - Established | Office | 181 | 154 | $94.25 | $17K |
| 99203 Office E&M - New | Office | 95 | 94 | $71.03 | $6,748 |
| 93000 Electrocardiogram | Office | 52 | 48 | $11.32 | $589 |
| 69210 Other Organ Systems | Office | 16 | 16 | $28.54 | $457 |
By year: 2022 $358K for 5,277 services; 2023 $333K for 5,171 services; 2024 $331K for 5,662 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 786 | 463 | $8.65 | $6,799 |
Medicare prescription drug claims, 2024
In 2024, the drug Manouchehr Rashti prescribed most often to Medicare patients was Diclofenac Sodium, with 1,553 prescriptions and refills. In total Manouchehr Rashti wrote 29,925 Medicare prescriptions that cost $6.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Diclofenac Sodium Generic | 1,553 | 1,643 | 356 | $974K |
| Rosuvastatin Calcium Generic | 1,272 | 2,552 | 308 | $11K |
| Vascepa Icosapent Ethyl | 1,155 | 1,501 | 236 | $501K |
| Gabapentin Generic | 685 | 936 | 206 | $4,497 |
| Amlodipine Besylate Generic | 663 | 1,395 | 178 | $2,179 |
| Metformin Hcl Generic | 583 | 1,164 | 149 | $1,714 |
| Escitalopram Oxalate Generic | 580 | 1,109 | 139 | $3,701 |
| Levothyroxine Sodium Generic | 554 | 1,092 | 116 | $3,660 |
| Icosapent Ethyl Generic | 534 | 791 | 160 | $121K |
| Dexlansoprazole Dr Dexlansoprazole | 487 | 680 | 94 | $113K |
| Fluticasone Propionate Generic | 467 | 504 | 227 | $3,522 |
| Linzess Linaclotide | 461 | 568 | 82 | $292K |
| Ozempic Semaglutide | 455 | 507 | 81 | $451K |
| Lidocaine Generic | 438 | 483 | 107 | $42K |
| Ezetimibe Generic | 435 | 834 | 104 | $6,116 |
Brand drugs: 8,467 claims; generic drugs: 21,305 claims; opioid claims: 99.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Manouchehr Rashti $3,529 ($3,529 in general payments such as food, travel and fees) from 24 companies. The largest payer was Abbvie Inc. with $887.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 37 | $887 |
| Ardelyx, Inc. ARDX | 11 | $374 |
| Amgen Inc. AMGN | 22 | $342 |
| Axsome Therapeutics, Inc. AXSM | 9 | $309 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $280 |
| Aimmune Therapeutics, Inc. | 8 | $192 |
| Novo Nordisk Inc NVO | 3 | $163 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $134 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $128 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $124 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.